Caterina Formichi

Dr. Caterina Formichi


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
DADonatella Ambroselli
Donatella Ambroselli
FMFabrizio Masciulli MASCIULLI
Fabrizio Masciulli MASCIULLI
Enrico RomanoEnrico Romano
Enrico Romano
giuseppina catanzarogiuseppina catanzaro
giuseppina catanzaro
ZBZein Mersini Besharat
Zein Mersini Besharat
Luisa ManninaLuisa Mannina
Luisa Mannina
The definition of metabolic syndrome (MetS) has undergone several changes over the years due to the difficulty in establishing universal criteria for it. Underlying the disorders related to MetS is almost invariably a pro-inflammatory state related to altered glucose metabolism, which could lead to elevated cardiovascular risk. Indeed, the complications closely related to MetS are cardiovascular diseases (CVDs) and type 2 diabetes (T2D). It has been observed that the predisposition to metabolic syndrome is modulated by complex interactions between human microbiota, genetic factors, and diet. This review provides a summary of the last decade of literature related to three principal aspects of MetS: (i) the syndrome’s definition and classification, pathophysiology, and treatment approaches; (ii) prediction and diagnosis underlying the biomarkers identified by means of advanced methodologies (NMR, LC/GC-MS, and LC, LC-MS); and (iii) the role of foods and food components in prevention and/or treatment of MetS, demonstrating a possible role of specific foods intake in the development of MetS.

25 October 2022 in Diabetologia
Verified
Journal Article
Open access
PDF file
NBNoemi Brusco
Noemi Brusco
Guido  SebastianiGuido Sebastiani
Guido Sebastiani
GGGianfranco Di Giuseppe
Gianfranco Di Giuseppe
GLGiada Licata
Giada Licata
GGGiuseppina Emanuela Grieco
Giuseppina Emanuela Grieco
TMTeresa Mezza
Teresa Mezza
Aims/hypothesis: Endoplasmic reticulum (ER) stress and beta cell dedifferentiation both play leading roles in impaired insulin secretion in overt type 2 diabetes. Whether and how these factors are related in the natural history of the disease remains, however, unclear. Methods: In this study, we analysed pancreas biopsies from a cohort of metabolically characterised living donors to identify defects in in situ insulin synthesis and intra-islet expression of ER stress and beta cell phenotype markers. Results: We provide evidence that in situ altered insulin processing is closely connected to in vivo worsening of beta cell function. Further, activation of ER stress genes reflects the alteration of insulin processing in situ. Using a combination of 17 different markers, we characterised individual pancreatic islets from normal glucose tolerant, impaired glucose tolerant and type 2 diabetic participants and reconstructed disease progression. Conclusions/interpretation: Our study suggests that increased beta cell workload is accompanied by a progressive increase in ER stress with defects in insulin synthesis and loss of beta cell identity. Graphical

2 July 2022 in Updates in Surgery
Verified
Journal Article
Open access
PDF file
CVCostantino Voglino
Costantino Voglino
SBSimona Badalucco
Simona Badalucco
ATAndrea Tirone
Andrea Tirone
CCCristina Ciuoli
Cristina Ciuoli
Silvia CantaraSilvia Cantara
Silvia Cantara
GVGiuseppe Vuolo
Giuseppe Vuolo
Bariatric surgery (BS) is the most effective treatment strategy for obesity. Nevertheless, a subset of patients does not reach a successful weight loss or experience long-term weight regain. Conflicting evidence exists regarding predictors of BS outcomes. We aimed to define the early factors linked to 3 year unsuccessful weight loss in order to promote a tailored close follow-up. We enrolled 443 patients who underwent BS from January 2014 to December 2018 with a 3 year follow-up. An unsuccessful BS outcome was defined as a percentage of total weight loss (%TWL) < 20. We compared the characteristics between successful and unsuccessful patients in order to identify predictor factors of unsuccess after surgery. We found that the proportion of patients with unsuccessful weight loss progressively increased from one to three years after BS. In a multiple regression model, only 1 month %TWL and sleeve gastrectomy (SG) were significantly associated with 3 year unsuccessful weight loss. We stratified our cohort in four groups according to the risk of BS unsuccess, in terms of 1 month %TWL and type of surgery (SG vs gastric bypass). Interestingly, groups showed a significant difference in terms of %TWL at each follow-up point. Patients submitted to SG with lower 1 month %TWL must be considered at higher risk of future weight regain; consequently, they require a tailored and closer follow-up.Graphical abstract

1 September 2021 in STAR Protocols
Verified
Journal Article
Open access
GGGiuseppina Emanuela Grieco
Giuseppina Emanuela Grieco
Guido  SebastianiGuido Sebastiani
Guido Sebastiani
DFDaniela Fignani
Daniela Fignani
NBNoemi Brusco
Noemi Brusco
LNLaura Nigi
Laura Nigi
FDFrancesco Dotta
Francesco Dotta
The identification and validation of circulating small non-coding RNA (sncRNA) as biomarkers for disease diagnosis, staging, and response to novel therapies is still a compelling challenge. Pre-analytical variables, such as storage temperature or blood hemolysis, and different analytical approaches affect sncRNA stability, detection, and expression, resulting in discrepancies among studies. Here, we report a systematic standardized protocol to reproducibly analyze circulating sncRNAs, employing high-throughput sncRNA sequencing and qRT-PCR validation, from 200 μL of human plasma samples.

29 April 2024 in Journal of Endocrinological Investigation
Verified
Journal Article
Open access
PDF file
CFCaterina Formichi
Caterina Formichi
WBW. Baronti
W. Baronti
GGG. de Gennaro
G. de Gennaro
MCM. Cerrai Ceroni
M. Cerrai Ceroni
LNL. Nigi
L. Nigi
FDF. Dotta
F. Dotta
Purpose: To evaluate the variables influencing the therapeutic choice toward oral versus subcutaneous semaglutide in a cohort of diabetic subjects. Methods: We retrospectively collected data of 292 patients followed at the Diabetes Unit of the University Hospital of Siena and the Hospital of Grosseto, who were prescribed oral (n = 115) or subcutaneous (n = 177) semaglutide between October 2021 and October 2022. Results: Oral semaglutide was preferentially prescribed in older subjects with longer disease duration in replacement of other antidiabetic drugs, while subcutaneous semaglutide was preferentially prescribed in add-on to metformin in subjects with higher body weight and BMI. After 6 months, both formulations significantly improved glycemic control and body weight, however injectable semaglutide showed a greater efficacy on A1c levels, weight loss, BMI and waist circumference reduction. No differences were found in terms of adverse events. Conclusion: In our experience, injectable semaglutide is preferred in patients with excess weight and shorter disease duration, while the oral formulation was used later and especially after therapeutic failure of previous therapies. Follow-up data indicate similar tolerability and efficacy of both formulations, despite subcutaneous semaglutide demonstrated greater efficacy.

8 March 2025 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Open access
CFCaterina Formichi
Caterina Formichi
SCSonia Caprio
Sonia Caprio
LNLaura Nigi
Laura Nigi
FDFrancesco Dotta
Francesco Dotta
This review aims to provide a comprehensive overview to understand the role of pollution in the development of noncommunicable diseases (NCDs), with a focus on metabolic diseases. In the context of NCDs, the incidence of metabolic diseases such as obesity and diabetes are increasing at an alarming rate. In addition to the well-known role of the so-called "obesogenic" environment, characterized by unhealthy diet and physical inactivity, great attention has been paid in recent years to the effects of pollution. Indeed, progressive urbanization has been associated with increased exposure to pollutants. The harmful effects of some pollutants on the endocrine system have been known for decades, but data on the metabolic impact of pollution are rather recent. Pollution in its various forms promotes a systemic inflammatory state, insulin resistance, and oxidative stress, which appear to be closely associated with increased risk of NCD, particularly obesity and diabetes. In conclusion, urbanization has so far had a predominantly negative impact on collective health, but a better understanding of the mechanisms linking pollution to metabolic health is crucial to implement preventive strategies, including careful urban planning to improve community health, understood not only as the absence of disease but also as psychological and social well-being, overcoming the risks associated with urbanization.